| See how to reach out for help or more product information. |
|
|
|
 |
| NovoSeven® RT is used to treat bleeding episodes in people with hemophilia A or B with inhibitors, congenital Factor VII deficiency, Glanzmann’s thrombasthenia with resistance to platelets, and acquired hemophilia. |
|
|
|
| Let our experience factor into your life. |
| For 30+ years, our research and experience has supported the hemophilia B with inhibitors community. Hear Miguel share his story and why he has trusted NovoSeven® RT for 20 years. |
|
|
|
| Miguel lives with hemophilia B with inhibitors. |
|
|
| Selected Important Safety Information |
| What is the most important information I should know about NovoSeven® RT? |
| NovoSeven® RT may cause serious side effects, including: |
| • |
Serious blood clots that form in veins and arteries with the use of
NovoSeven® RT have been reported
|
|
| • |
Your healthcare provider should discuss the risks and explain the signs and symptoms
of blood clots to you. Some signs of a blood clot may include pain, swelling,
warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or
sudden severe headache and/or loss of consciousness or function
|
|
| • |
Your healthcare provider should monitor you for blood clots during treatment with
NovoSeven® RT
|
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
| Made with your needs in mind. |
| Providing people with hemophilia and inhibitors a product that is effective and stops bleeds quickly is our priority. NovoSeven® RT offers fast bleed control in even the most life-threatening bleeds.a |
|
|
|
|
| aIn compassionate use situations including surgery, central nervous system hemorrhages, severe intra-abdominal bleeding, and other life-threatening bleeding episodes. |
| bAll bleeds: joint, target joint, skin, mucous membrane, muscle, and other bleeding episodes (n=227 bleeding episodes). |
| cAdminister as a slow bolus injection over 2 to 5 minutes, depending on the dose administered. |
| dIndividual doses (NovoSeven® RT 90 mcg/kg and FEIBA 75 U/kg) are compared and based on an 88-kg (194-lb) person. |
| ePatients are cautioned that the maximum injection or infusion rate must not exceed 2 units per kilogram of body weight per minute. |
|
|
| Drop us a line if you want to connect. |
|
| Your Hemophilia Community Liaison (HCL) is ready to provide personalized support for life with a bleeding disorder. Connect with a local HCL to ask about our product assistance programs and other resources. |
|
|
|
|
|
| What is NovoSeven® RT? |
| NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for: |
| • |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions |
|
| • |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia |
|
| Important Safety Information (cont’d) |
| • |
You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness |
|
| What should I tell my healthcare provider before using NovoSeven® RT? |
| • |
Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots: |
| |
| ◦ |
congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates) |
| ◦ |
are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding |
| ◦ |
history of heart or blood vessel diseases |
|
| • |
Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies |
|
| What are the possible side effects of NovoSeven® RT? |
| • |
The most common and serious side effects are blood clots |
|
| • |
Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction |
|
| Please click here for Prescribing Information. |
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
| PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579. |
|
NovoSeven® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2020 Novo Nordisk All rights reserved. US20NSVN00094 October 2020 |
 |
|
|
|
